BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 21, 2018
View Archived Issues
Study investigates IL-6 monoclonal antibody as a treatment for depression
Read More
Phase I data presented for T cells expressing an anti-CD19 CAR
Read More
ITTP demonstrates initial evidence of antitumoral activity in first-in-human trial
Read More
NovImmune presents data supporting approval of emapalumab for hemophagocytic lymphohistiocytosis
Read More
Phase IIb results for pimodivir alone or in combination with oseltamivir for seasonal influenza A
Read More
LncRNAs are gene trainers
Read More
Zinc plus its transporter kill resistant bacteria
Read More
Novel proteolysis-targeting chimeras degrading FLT3 and FAK
Read More
Fimepinostat may sensitize FLT3/ITD acute myeloid leukemia to gilteritinib
Read More
Metabolic strategy could tackle HIV reservoir, other infections
Read More
Carmot initiates phase I study of CT-868
Read More
Surface Oncology reduces scope of CD47 program SRF-231
Read More
Apexigen and with Columbia University Irving Medical Center collaborate on new phase II trial
Read More
Topline data presented from phase I studies of LX-2761
Read More
INmune Bio cleared to begin phase I study of INKmune in ovarian cancer
Read More
DWTI announces results of phase I/IIa study of H-1337
Read More
Novel anti-BMP6 targeted antibody reduces the need for EPO in anemia of chronic disease models
Read More
PASD1 found as immunotherapeutic target in colorectal cancer
Read More
FDA grants permission to initiate first-in-human study of ASN-008
Read More
Kalytera reports first cohort interim data from phase II trial of CBD in acute GvHD
Read More
Trial of TG-4001 with avelumab for HPV16-positive cancer advances into phase II
Read More
Bevespi Aerosphere approved in Europe for COPD
Read More
OSE-127 begins first-in-human trial for treatment of inflammatory autoimmune diseases
Read More
First patients enrolled in phase II SHIELD study of DAV-132
Read More
FDA clears Sirnaomics to begin phase II study of STP-705 for nonmelanoma skin cancer
Read More
Pfizer to discontinue STRIVE study of S. aureus vaccine due to futility
Read More
ARCHES study of Xtandi in metastatic hormone-sensitive prostate cancer meets primary endpoint
Read More